AirNexis Therapeutics launches with $200M tranched Series A targeting COPD by mariel | Mar 3, 2026 | Portfolio News
CG Oncology accelerates Phase 3 PIVOT-006 readout to H1 2026 by mariel | Feb 27, 2026 | Portfolio News
FDA grants Priority Review to Vera Therapeutics’ BLA for atacicept in IgA nephropathy; PDUFA date July 7, 2026; completes $800M combined equity and debt financing to support commercial readiness by mariel | Feb 26, 2026 | Portfolio News
OrsoBio reports positive Phase 2a proof-of-concept results for TLC-2716 in hypertriglyceridemia and MASLD by mariel | Feb 10, 2026 | Portfolio News
Veradermics completes IPO; begins trading on NYSE under ticker “MANE” by mariel | Feb 4, 2026 | Portfolio NewsVeradermics closed an oversubscribed Series C in 4Q25 and subsequently completed its IPO, with shares beginning to trade under ticker MANE.
